- Home
- COLL vs PMT Comparison
COLL vs PMT Comparison
Compare COLL & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- PMT
- Stock Information
- Founded
- COLL 2002
- PMT 2009
- Country
- COLL United States
- PMT United States
- Employees
- COLL N/A
- PMT N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- PMT Real Estate Investment Trusts
- Sector
- COLL Health Care
- PMT Real Estate
- Exchange
- COLL Nasdaq
- PMT Nasdaq
- Market Cap
- COLL 958.8M
- PMT 1.1B
- IPO Year
- COLL 2015
- PMT 2009
- Fundamental
- Price
- COLL $32.38
- PMT $13.15
- Analyst Decision
- COLL Strong Buy
- PMT Buy
- Analyst Count
- COLL 4
- PMT 9
- Target Price
- COLL $43.75
- PMT $14.75
- AVG Volume (30 Days)
- COLL 296.7K
- PMT 731.1K
- Earning Date
- COLL 08-07-2025
- PMT 07-22-2025
- Dividend Yield
- COLL N/A
- PMT 12.19%
- EPS Growth
- COLL N/A
- PMT N/A
- EPS
- COLL 1.25
- PMT 0.86
- Revenue
- COLL $664,283,000.00
- PMT $591,251,000.00
- Revenue This Year
- COLL $20.04
- PMT N/A
- Revenue Next Year
- COLL $3.98
- PMT $15.69
- P/E Ratio
- COLL $25.18
- PMT $15.28
- Revenue Growth
- COLL 17.17
- PMT N/A
- 52 Week Low
- COLL $23.23
- PMT $11.77
- 52 Week High
- COLL $42.29
- PMT $14.98
- Technical
- Relative Strength Index (RSI)
- COLL 71.18
- PMT 63.59
- Support Level
- COLL $30.60
- PMT $13.03
- Resistance Level
- COLL $31.99
- PMT $13.32
- Average True Range (ATR)
- COLL 0.80
- PMT 0.24
- MACD
- COLL 0.17
- PMT 0.07
- Stochastic Oscillator
- COLL 95.50
- PMT 91.17
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.